Eiken Chemical Co., Ltd. (JP:4549)
:4549
Want to see JP:4549 full AI Analyst Report?
4549 Stock Chart & Stats
¥2407.00
-¥16.00(-0.73%)
At close: 4:00 PM EST
¥2407.00
-¥16.00(-0.73%)
Day’s Range― - ―
52-Week Range¥1,972.00 - ¥3,500.00
Previous CloseN/A
Volume82.20K
Average Volume (3M)72.32K
Market Cap
¥96.14B
Enterprise Value¥94.88B
Total Cash (Recent Filing)¥4.67B
Total Debt (Recent Filing)¥3.00B
Price to Earnings (P/E)27.2
Beta0.63
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.31%
Share Statistics
EPS (TTM)68.66
Shares Outstanding34,541,440
10 Day Avg. Volume81,940
30 Day Avg. Volume72,320
Financial Highlights & Ratios
PEG Ratio0.37
Price to Book (P/B)2.29
Price to Sales (P/S)2.40
P/FCF Ratio-58.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)91.9
Revenue Forecast (FY)¥43.56B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a large equity cushion provide durable financial flexibility, allowing the company to fund R&D, capital equipment placements, or absorb cyclical shocks without relying heavily on external financing. This stability supports long-term investment and optionality.
Recurring Consumable Revenue ModelA business model centered on consumable reagents and installed analyzers creates predictable, repeat purchase demand and steady revenue streams. Installed-base driven consumable pull-through supports medium-term revenue visibility and resilience versus one-off product cycles.
Proprietary LAMP Molecular PlatformOwnership of a differentiated LAMP amplification platform gives a structural competitive edge in molecular diagnostics, enabling product differentiation, targeted assay development, and potential licensing or partnerships that can expand addressable markets and support higher-margin product opportunities.
Bears Say
Negative Free Cash FlowA shift to negative free cash flow signals weaker cash conversion and potential working-capital strain or elevated investment spending. Sustained negative FCF limits internal funding for dividends, R&D and capex, increasing reliance on reserves or external financing over the medium term.
Material Margin CompressionSignificant contraction in gross and operating margins reduces the firm's ability to fund growth and absorb cost shocks. If driven by structural pricing or mix shifts, compressed margins can persistently lower returns and constrain reinvestment in product development and commercialization.
Weak Revenue RecoveryA shallow rebound after a sharp revenue drop indicates demand headwinds or slower market share recovery. Limited top-line momentum reduces operating leverage benefits and makes medium-term growth dependent on new product wins or market expansion rather than organic recovery.
Eiken Chemical Co., Ltd. News
4549 FAQ
What was Eiken Chemical Co., Ltd.’s price range in the past 12 months?
Eiken Chemical Co., Ltd. lowest stock price was ¥1972.00 and its highest was ¥3500.00 in the past 12 months.
What is Eiken Chemical Co., Ltd.’s market cap?
Eiken Chemical Co., Ltd.’s market cap is ¥96.14B.
When is Eiken Chemical Co., Ltd.’s upcoming earnings report date?
Eiken Chemical Co., Ltd.’s upcoming earnings report date is Jul 29, 2026 which is in 69 days.
How were Eiken Chemical Co., Ltd.’s earnings last quarter?
Eiken Chemical Co., Ltd. released its earnings results on May 12, 2026. The company reported -¥0.42 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.42.
Is Eiken Chemical Co., Ltd. overvalued?
According to Wall Street analysts Eiken Chemical Co., Ltd.’s price is currently Overvalued.
Does Eiken Chemical Co., Ltd. pay dividends?
Eiken Chemical Co., Ltd. pays a Semiannually dividend of ¥29 which represents an annual dividend yield of 2.31%. See more information on Eiken Chemical Co., Ltd. dividends here
What is Eiken Chemical Co., Ltd.’s EPS estimate?
Eiken Chemical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eiken Chemical Co., Ltd. have?
Eiken Chemical Co., Ltd. has 34,541,440 shares outstanding.
What happened to Eiken Chemical Co., Ltd.’s price movement after its last earnings report?
Eiken Chemical Co., Ltd. reported an EPS of -¥0.42 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.793%.
Which hedge fund is a major shareholder of Eiken Chemical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4549
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.
Technical Analysis
PHC Holdings Corp.
―
Techno Medica Co., Ltd.
―
Rion Co., Ltd.
―
Nihon Kohden Corporation
―
Options Prices
Currently, No data available
---